These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29572080)

  • 1. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
    Proietti M; Romiti GF; Romanazzi I; Farcomeni A; Staerk L; Nielsen PB; Lip GYH
    Int J Cardiol; 2018 Jun; 261():84-91. PubMed ID: 29572080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
    Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016.
    Newman TV; Chen N; He M; Saba S; Hernandez I
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restarting of anticoagulation in patients with atrial fibrillation after major bleeding: A meta-analysis.
    Zhou Y; Guo Y; Liu D; Feng H; Liu J
    J Clin Pharm Ther; 2020 Aug; 45(4):591-601. PubMed ID: 32181518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis.
    Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
    Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines.
    Yang H; Heidendael JF; de Groot JR; Konings TC; Veen G; van Dijk APJ; Meijboom FJ; Sieswerda GT; Post MC; Winter MM; Mulder BJM; Bouma BJ
    Int J Cardiol; 2018 Apr; 257():67-74. PubMed ID: 29506740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.
    Lilli A; Di Cori A; Zacà V
    Clin Cardiol; 2017 Sep; 40(9):641-647. PubMed ID: 28471498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Masunaga N; Abe M; Ogawa H; Aono Y; Ikeda S; Doi K; An Y; Ishii M; Iguchi M; Esato M; Tsuji H; Wada H; Hasegawa K; Lip GYH; Akao M;
    Circ J; 2018 Nov; 82(12):2983-2991. PubMed ID: 30381701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of stroke and bleeding post-atrial fibrillation ablation.
    Joza J; Samuel M; Jackevicius CA; Behlouli H; Jia J; Koh M; Tsadok MA; Tang ASL; Verma A; Pilote L; Essebag V
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1355-1362. PubMed ID: 30047574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding.
    Kozieł M; Ding WY; Kalarus Z; Lip GYH
    Expert Rev Hematol; 2019 Oct; 12(10):845-855. PubMed ID: 31334670
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis.
    Papanastasiou A; Morsi-Yeroyannis A; Karagiannidis E; Kartas A; Doundoulakis I; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2021; 62(5):359-365. PubMed ID: 33242617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.